NEXTGEN HEALTHCARE INC (NXGN) Stock Fundamental Analysis
USA - NASDAQ:NXGN - US65343C1027 - Common Stock
23.94 USD
+0.03 (+0.13%)
23.93 USD
-0.01 (-0.04%)
Overall NXGN gets a fundamental rating of 4 out of 10. We evaluated NXGN against 35 industry peers in the Health Care Technology industry. Both the profitability and the financial health of NXGN get a neutral evaluation. Nothing too spectacular is happening here. NXGN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year NXGN was profitable.
NXGN had a negative operating cash flow in the past year.
Of the past 5 years NXGN 4 years were profitable.
Each year in the past 5 years NXGN had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -0.72%, NXGN is doing good in the industry, outperforming 78.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.47%, NXGN is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
With a decent Return On Invested Capital value of 0.82%, NXGN is doing good in the industry, outperforming 78.57% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for NXGN is below the industry average of 6.80%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.72% | ||
| ROE | -1.47% | ||
| ROIC | 0.82% |
ROA(3y)0.48%
ROA(5y)1.41%
ROE(3y)0.64%
ROE(5y)2.06%
ROIC(3y)1.91%
ROIC(5y)2.95%
1.3 Margins
With a decent Operating Margin value of 1.06%, NXGN is doing good in the industry, outperforming 78.57% of the companies in the same industry.
NXGN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 46.40%, NXGN is in line with its industry, outperforming 42.86% of the companies in the same industry.
NXGN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.06% | ||
| PM (TTM) | N/A | ||
| GM | 46.4% |
OM growth 3Y-58.31%
OM growth 5Y-27.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-2.66%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NXGN is destroying value.
The number of shares outstanding for NXGN has been reduced compared to 1 year ago.
NXGN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NXGN has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.59 indicates that NXGN is not in any danger for bankruptcy at the moment.
NXGN has a Altman-Z score of 3.59. This is in the better half of the industry: NXGN outperforms 78.57% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that NXGN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, NXGN is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.59 |
ROIC/WACC0.08
WACC10.14%
2.3 Liquidity
A Current Ratio of 2.52 indicates that NXGN has no problem at all paying its short term obligations.
NXGN has a Current ratio of 2.52. This is comparable to the rest of the industry: NXGN outperforms 50.00% of its industry peers.
A Quick Ratio of 2.52 indicates that NXGN has no problem at all paying its short term obligations.
NXGN has a Quick ratio (2.52) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.52 | ||
| Quick Ratio | 2.52 |
3. Growth
3.1 Past
NXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
Measured over the past 5 years, NXGN shows a small growth in Earnings Per Share. The EPS has been growing by 6.96% on average per year.
Looking at the last year, NXGN shows a quite strong growth in Revenue. The Revenue has grown by 13.25% in the last year.
The Revenue has been growing slightly by 4.23% on average over the past years.
EPS 1Y (TTM)33.33%
EPS 3Y5.69%
EPS 5Y6.96%
EPS Q2Q%24%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y6.53%
Revenue growth 5Y4.23%
Sales Q2Q%10.65%
3.2 Future
NXGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.15% yearly.
The Revenue is expected to grow by 7.76% on average over the next years.
EPS Next Y14.49%
EPS Next 2Y17.83%
EPS Next 3Y17.28%
EPS Next 5Y17.15%
Revenue Next Year11.2%
Revenue Next 2Y9.22%
Revenue Next 3Y8.41%
Revenue Next 5Y7.76%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 21.38, NXGN is valued on the expensive side.
Based on the Price/Earnings ratio, NXGN is valued cheaper than 92.86% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.91, NXGN is valued a bit cheaper.
A Price/Forward Earnings ratio of 17.59 indicates a rather expensive valuation of NXGN.
92.86% of the companies in the same industry are more expensive than NXGN, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.92, NXGN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.38 | ||
| Fwd PE | 17.59 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NXGN is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 34.12 |
4.3 Compensation for Growth
NXGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NXGN's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.48
PEG (5Y)3.07
EPS Next 2Y17.83%
EPS Next 3Y17.28%
5. Dividend
5.1 Amount
No dividends for NXGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
23.94
+0.03 (+0.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners0%
Inst Owner Change0%
Ins Owners31.12%
Ins Owner Change0%
Market Cap1.61B
Revenue(TTM)695.05M
Net Income(TTM)-6214000
Analysts50.77
Price Target24.41 (1.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.71
Dividend Growth(5Y)3.39%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.08%
Min EPS beat(2)6.95%
Max EPS beat(2)23.21%
EPS beat(4)3
Avg EPS beat(4)7.54%
Min EPS beat(4)-6.17%
Max EPS beat(4)23.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.72%
Revenue beat(4)2
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-2.26%
Max Revenue beat(4)2.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.11%
PT rev (3m)16.34%
EPS NQ rev (1m)-2.38%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.38 | ||
| Fwd PE | 17.59 | ||
| P/S | 2.31 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.8 | ||
| P/tB | 94.94 | ||
| EV/EBITDA | 34.12 |
EPS(TTM)1.12
EY4.68%
EPS(NY)1.36
Fwd EY5.68%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS10.36
BVpS6.31
TBVpS0.25
PEG (NY)1.48
PEG (5Y)3.07
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.72% | ||
| ROE | -1.47% | ||
| ROCE | 1.04% | ||
| ROIC | 0.82% | ||
| ROICexc | 1.14% | ||
| ROICexgc | 5.45% | ||
| OM | 1.06% | ||
| PM (TTM) | N/A | ||
| GM | 46.4% | ||
| FCFM | N/A |
ROA(3y)0.48%
ROA(5y)1.41%
ROE(3y)0.64%
ROE(5y)2.06%
ROIC(3y)1.91%
ROIC(5y)2.95%
ROICexc(3y)2.27%
ROICexc(5y)3.46%
ROICexgc(3y)18.71%
ROICexgc(5y)23.54%
ROCE(3y)2.41%
ROCE(5y)3.74%
ROICexgc growth 3Y-50.16%
ROICexgc growth 5Y-31.62%
ROICexc growth 3Y-56.26%
ROICexc growth 5Y-28.38%
OM growth 3Y-58.31%
OM growth 5Y-27.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-2.66%
F-Score2
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.98 | ||
| Cap/Depr | 95.52% | ||
| Cap/Sales | 5.14% | ||
| Interest Coverage | 1.1 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.52 | ||
| Quick Ratio | 2.52 | ||
| Altman-Z | 3.59 |
F-Score2
WACC10.14%
ROIC/WACC0.08
Cap/Depr(3y)75.15%
Cap/Depr(5y)68.18%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3Y5.69%
EPS 5Y6.96%
EPS Q2Q%24%
EPS Next Y14.49%
EPS Next 2Y17.83%
EPS Next 3Y17.28%
EPS Next 5Y17.15%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y6.53%
Revenue growth 5Y4.23%
Sales Q2Q%10.65%
Revenue Next Year11.2%
Revenue Next 2Y9.22%
Revenue Next 3Y8.41%
Revenue Next 5Y7.76%
EBIT growth 1Y-70.75%
EBIT growth 3Y-55.58%
EBIT growth 5Y-24.47%
EBIT Next Year47.96%
EBIT Next 3Y27.47%
EBIT Next 5Y21.11%
FCF growth 1Y-203.01%
FCF growth 3Y-52.24%
FCF growth 5Y-32.4%
OCF growth 1Y-110.78%
OCF growth 3Y-20.1%
OCF growth 5Y-10.01%
NEXTGEN HEALTHCARE INC / NXGN FAQ
What is the fundamental rating for NXGN stock?
ChartMill assigns a fundamental rating of 4 / 10 to NXGN.
What is the valuation status of NEXTGEN HEALTHCARE INC (NXGN) stock?
ChartMill assigns a valuation rating of 3 / 10 to NEXTGEN HEALTHCARE INC (NXGN). This can be considered as Overvalued.
How profitable is NEXTGEN HEALTHCARE INC (NXGN) stock?
NEXTGEN HEALTHCARE INC (NXGN) has a profitability rating of 4 / 10.
What is the earnings growth outlook for NEXTGEN HEALTHCARE INC?
The Earnings per Share (EPS) of NEXTGEN HEALTHCARE INC (NXGN) is expected to grow by 14.49% in the next year.
Can you provide the dividend sustainability for NXGN stock?
The dividend rating of NEXTGEN HEALTHCARE INC (NXGN) is 0 / 10 and the dividend payout ratio is 0%.